Little is known about the interactions between ovarian hormones and respons
es to psychoactive drugs in humans. Preclinical studies suggest that ovaria
n hormones such as estrogen and progesterone have direct and indirect centr
al nervous system actions and that these hormones can influence behavioral
responses to psychoactive drugs. In the present study, we assessed the subj
ective and physiological effects of d-amphetamine (AMPH; 10 mg p.o.) after
pretreatment with estradiol. Two groups of healthy, regularly cycling women
participated in two sessions scheduled during the early follicular phases
of two menstrual cycles. One group received estradiol patches (Estraderm TT
S; 0.8 mg) which elevated plasma estradiol levels to approximately 750 pg/
mi on both sessions; the other group received placebo patches on both sessi
ons. Both groups received AMPH (10.0 mg) and placebo in a randomized and co
unterbalanced order on the two sessions. Dependent measures included self-r
eport questionnaires, physiological measures, and plasma hormone levels. Mo
st of the subjective and physiological effects of AMPH were not affected by
acute estradiol treatment. Nevertheless, estradiol pretreatment increased
the magnitude of the effects of AMPH on subjective ratings of 'pleasant sti
mulation' and decreased ratings of 'want more'. Also, estradiol produced so
me subjective effects when administered alone: It increased subjective rati
ngs of 'feel drug','energy and intellectual efficiency', and 'pleasant stim
ulation'. These results provide limited evidence that the stimulating effec
ts of AMPH are increased by acute estradiol pretreatment. Copyright (C) 200
0 S. Karger AG, Basel.